Professor John Campbell is Associate Director of Tissues, Cells and Advanced Therapeutics at the Scottish National Blood Transfusion Service (SNBTS) in Edinburgh. He completed his PhD in Pathology at Edinburgh in 1995, and has worked in the cellular therapy field for 30 years in the academic, industrial and healthcare sectors. Whilst working in industry, he was heavily involved in development of reagents and equipment to drive manufacture and characterization of cellular therapeutics. He is currently the national head of research for SNBTS and holds academic appointments at the Universities of Glasgow and Edinburgh. SNBTS has a substantial cellular therapy research and manufacturing programme, with over 90 full time scientists working on basic cellular function; translation of laboratory protocols to full GMP processes; and manufacturing of tissue and cellular therapeutics. SNBTS has a two fully MHRA licensed, GMP cellular therapy production centres at the Scottish Centre for Regenerative Medicine and the Jack Copland Centre, Edinburgh. SNBTS also runs a fully MHRA-accredited Flow Cytometry lab for characterization of cellular products. Cellular therapeutics in development and early phase clinical trials include, mesenchymal stromal cells, corneal limbal stem cells, macrophages for tissue repair and virus-specific T Lymphocytes for the treatment of tumours.